Second simulation round
Our goal
After our first successful publication in Nature Methods, we are back to increase the data coverage of GPCRmd in a 2nd simulation round.
In this round, we will focus on simulating all remaining PDB IDs which correspond to GPCRs which are not in complex with G proteins, arrestins, or nanobodies. Note that GPCR-G protein/arrestin/nanobody complexes will be addressed in the 3rd simulation round starting in January 2021.
Collaborators
- David Aranda-García, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Davide Abbondandolo, University of Bologna (Bologna, Italy)
- Arnau Cordomi, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Miguel Dieguez, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Matthaeus Drabek, Philipps-Univirsity of Marburg (Marburg, Germany)
- Slawomir Filipek, University of Warsaw (Warsaw, Poland)
- Toni Giorgino, National Research Council of Italy (Milan, Italy), University of Milan (Milan, Italy)
- Ramon Guixà-González, Paul Scherrer Institute (Villigen PSI, Switzerland)
- Hugo Gutiérrez-de-Terán, Uppsala University (Uppsala, Sweden)
- Célien Jacquemard, University of Strasbourg (Strasbourg, France)
- Willem Jespers, Uppsala University (Uppsala, Sweden)
- Mireia Jiménez-Rosés, Sygnature Discovery (Notingham, UK)
- Víctor Jun-Yu-Lim, Philipps-Univirsity of Marburg (Marburg, Germany)
- Peter Kolb, Philipps-University Marburg (Marburg, Germany)
- Dorota Latek, University of Warsaw (Warsaw, Poland)
- Marta Lopez-Balastegui, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Tomasz Maciej Stepniewski, InterAx Biotech AG (Zurich, Switzerland)
- Maria Marti-Solano, MRC Laboratory of Molecular Biology (Cambridge, UK), Philipps-University Marburg (Marburg, Germany)
- Brian Medel-Lacruz, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Adrián Morales-Pastor, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Alessandro Nicoli, Leibniz-Institute for Food Systems Biology at the Technical University of Munich (Freising, Germany)
- Alejandro Peralta-García, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Antonella Di Pizio, Leibniz-Institute for Food Systems Biology at the Technical University of Munich (Freising, Germany)
- David Sotillo-Nuñez, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Johanna K. S. Tiemann, University of Copenhagen (Copenhagen, Denmark), Medical University Leipzig (Leipzig, Germany), Charite University Medicine Berlin (Berlin, Germany)
- Irina Tikhonova, Queen's University Belfast (Belfast, UK)
- Mariona Torrens-Fontanals, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Aida Shahraki, Philipps-Univirsity of Marburg (Marburg, Germany)
- Jana Selent, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)